Charles University in Prague-ko ikertzaileekin lankidetzan egindako argitalpenak (21)

2023

  1. Experience with IVDR Implementation in Three Diagnostic Laboratories: Messages to EU Health Institutions, Diagnostic Healthcare Payers, and Authorities

    HemaSphere

2019

  1. Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies

    Journal of Allergy and Clinical Immunology, Vol. 144, Núm. 3, pp. 809-824

  2. Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia

    Journal of Immunological Methods, Vol. 475

  3. Fluorochrome choices for multi-color flow cytometry

    Journal of Immunological Methods, Vol. 475

  4. Lot-to-lot stability of antibody reagents for flow cytometry

    Journal of Immunological Methods, Vol. 475

  5. Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples

    Journal of Immunological Methods, Vol. 475

  6. Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab

    Blood

2018

  1. Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood

    Journal of Allergy and Clinical Immunology, Vol. 141, Núm. 6, pp. 2208-2219.e16

2017

  1. Genetic defects in PI3Kδ affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections

    Clinical Immunology, Vol. 176, pp. 77-86

2014

  1. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes

    Journal of Allergy and Clinical Immunology, Vol. 133, Núm. 4

2013

  1. The MLL recombinome of acute leukemias in 2013

    Leukemia, Vol. 27, Núm. 11, pp. 2165-2176

2012

  1. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes

    Leukemia, Vol. 26, Núm. 9, pp. 1908-1975

  2. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols

    Leukemia, Vol. 26, Núm. 9, pp. 1986-2010

  3. Flow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemia

    Leukemia, Vol. 26, Núm. 9, pp. 1976-1985

2010

  1. Detection of fusion genes at the protein level in leukemia patients via the flow cytometric immunobead assay

    Best Practice and Research: Clinical Haematology, Vol. 23, Núm. 3, pp. 333-345

  2. Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: A European MCL intergroup study

    Blood, Vol. 115, Núm. 16, pp. 3215-3223

2009

  1. Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients

    Leukemia, Vol. 23, Núm. 6, pp. 1106-1117

  2. New insights to the MLL recombinome of acute leukemias

    Leukemia, Vol. 23, Núm. 8, pp. 1490-1499

2007

  1. Analysis of minimal residual disease by Ig/TCR gene rearrangements: Guidelines for interpretation of real-time quantitative PCR data

    Leukemia

  2. Childhood secondary ALL after ALL treatment

    Leukemia, Vol. 21, Núm. 7, pp. 1431-1435